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Abstract 
Circulating miRNAs in body fluids, particularly serum, are promising candidates for future routine biomarker profil-
ing in various pathologic conditions in human and veterinary medicine. However, reliable standardized methods for 
miRNA extraction from equine serum and fresh or archived whole blood are sorely lacking. We systematically com-
pared various miRNA extraction methods from serum and whole blood after short and long-term storage without 
addition of RNA stabilizing additives prior to freezing. Time of storage at room temperature prior to freezing did 
not affect miRNA quality in serum. Furthermore, we showed that miRNA of NGS-sufficient quality can be recovered 
from blood samples after >10 years of storage at −80 °C. This allows retrospective analyses of miRNAs from archived 
samples.
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Findings
Non-coding microRNAs (miRNAs), amongst other small 
RNAs, play an important role in shaping a cell’s tran-
scriptome profile by regulation of mRNA transcription 
and/or translation [1] and may thus affect multiple target 
genes. In human medicine, miRNAs are promising diag-
nostic and prognostic biomarkers in cancer and other 
complex diseases [2].
In equine medicine, the knowledge about miRNAs in 
physiologic and pathologic conditions is still very limited 
restricted to certain diseases only, and thus warrants fur-
ther investigation in this species [3–6].
In contrast to mRNA, miRNA molecules are surpris-
ingly stable—even in tissue samples of compromised 
quality [7]—which supports the possibility of routine use 
of miRNA fingerprints as biomarkers in clinical practice. 
Small RNA extraction methods have been established for 
model organisms like human and mouse. Still, optimized 
procedures for circulating miRNA extraction might differ 
among species and there is little experience with extrac-
tion from equine samples [8, 9]. In serum and plasma, 
extracellular miRNAs are only present in low concentra-
tions and their exact measurements may be affected by 
interference with DNA, degraded RNA, erythrocyte-
derived miRNAs, and blood contaminants like heme and 
immunoglobulins [10, 11].
For miRNA studies using equine EDTA blood, the 
use of PAXgene blood RNA tubes in combination with 
the PAXgene blood RNA extraction kit was recom-
mended [6]. However, particularly for retrospective stud-
ies, archived blood samples stored for years without any 
RNA stabilizing additives may be the only available mate-
rial. The aim of our study was to compare different meth-
ods for the isolation of miRNAs from equine serum, fresh 
and archived EDTA blood samples.
For miRNA extraction from serum samples we 
assessed how RNA yield is affected by the performance 
of three column-based and one column-free method, two 
different lysis reagents, and the effects of storage time at 
room temperature (RT), serum input volume, perform-
ing a second phenol extraction, and a second column elu-
tion. We performed our analysis on serum samples from 
three horses. As we assessed a large number of different 
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parameters, we did not analyse all possible 576 combi-
nations, but rather chose an incomplete matrix of 60 
combinations that allowed us to address each of the six 
investigated parameters (Additional file 1).
RNA isolation was performed according to the pro-
tocols of the four different manufacturers: ZR Whole-
Blood RNA MiniPrep, Zymo Reasearch; Direct-zol RNA 
MiniPrep, Zymo Research; miRNeasy Serum/Plasma 
Kit, Qiagen), and standard TRIzol method [12]. The kits 
resulted in comparable miRNA yields that ranged from 
0.13 to 0.64 ng RNA/100 μl serum (Table 1). The Direct-
zol RNA MiniPrep was the fastest procedure, however, it 
had the lowest maximum sample loading volume (up to 
100 μl). The highest final concentrations of the isolated 
small RNA were obtained with the miRNeasy and TRI-
zol methods (up to 138  pg/μl, Table  1). We chose the 
miRNeasy serum/plasma kit as our preferred method as 
the column-based purification is less prone to handling 
errors. The use of TRIzol as lysis buffer in combination 
with miRNeasy columns revealed similar results in terms 
of RNA yield as QIAzol, which is recommended by the 
manufacturer (Wilcoxon signed rank test P = 0.57).
We next assessed the effect of serum storage times on 
the performance of the miRNeasy method (Additional 
File 1). Serum aliquots were stored for 1, 5, or 24  h at 
RT before freezing at −80 °C. The storage time at RT did 
not have a significant effect on the RNA yield per 100 μl 
serum used (Kruskal–Wallis test P  =  0.12) (Additional 
file 1).
To increase the efficiency of the RNA extraction with 
miRNeasy serum/plasma kit the following procedures 
were tested: (1) second extraction: by adding 600  μl 
RNase-free water to the remaining organic phase, and 
further steps as indicated by the manufacturer; (2) sec-
ond elution: re-using the first eluate; and (3) increased 
serum volume: 5× or 10× multiplication of 200 μl serum 
processed individually for the phase separation and then 
loaded sequentially on a single column (Additional file 1). 
The second elution did not show a significant increase 
in RNA yield (Wilcoxon signed rank test P =  0.07) and 
after the second extraction RNA was no longer detect-
able and therefore none of those steps were considered 
as advantageous. Increased serum volume improved the 
RNA yield in samples processed with QIAzol, therefore, 
1 ml of serum was chosen as the minimum and 2 ml as 
the optimum volume balancing RNA yield and the time 
required for the procedure.
To further assess the quality of the small RNA extracted 
with the optimised procedure we used six serum small 
RNA samples (36–174 ng) for next generation sequenc-
ing on a MiSeq (Additional file  1). Pre-processed 
sequencing reads in FASTQ format are available at http://
www.ebi.ac.uk/ena/data/view/PRJEB10829. Read length 
distribution revealed a peak within the miRNA range and 
an even higher peak within the piRNA range (Fig. 1). This 
was in agreement with a previous study performed on pig 
serum [9]. 
To corroborate our findings we isolated 120 miRNA 
samples with the optimized protocol (Additional file  2). 
The RNA yield ranged from 4 to 876  ng/100 μl serum 
(mean = 39 ng/100 μl serum). Only two samples showed 
high level of haemolysis and therefore the effect of hae-
molysis on serum RNA content [13] could not be investi-
gated in this study.
For the optimization of miRNA extraction from 
archived EDTA blood samples we compared the PAX-
gene blood RNA kit with the PAXgene blood miRNA 
kit that is designed specifically for small RNA enrich-
ment. For this comparison we used six horse EDTA 
samples stored for 12  weeks, 5 or 11  years (Additional 
Table 1 Small RNA extraction kit comparison
RNA extraction results with different kits used. Due to differences in serum and elution volumes used, the RNA/miRNA concentration is given in RNA per 100μl of 
serum. RNA was measured with Nanodrop and miRNA with Bioanalyzer. The concentration was not measurable with the Qubit high sensitivity RNA kit. Due to very 
low concentration, the Nanodrop results should be treated with caution
Kit Horse ID Serum  
volume (μl)
RNA concentration, 
Nanodrop (ng/μl)
Elution  
volume (μl)
Small RNA  
concentration,  
Bioanalyzer (pg/μl)
miRNA in small 
RNA (%)
miRNA/100 μl 
serum (ng)
ZR WB 1 200 1.85 8 89.4 46 0.17
ZR WB 3 200 3.65 8 69.5 63 0.18
Direct-zol 1 100 2.70 50 15.0 86 0.64
Direct-zol 3 100 0.45 50 12.8 53 0.34
miRNeasy 1 200 56.23 12 30.4 72 0.13
miRNeasy 3 200 11.69 12 126.2 77 0.58
TRIzol 1 400 52.98 10 138.5 63 0.22
TRIzol 3 400 138.21 10 127.9 43 0.14
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file  3) at −80  °C without addition of RNA stabilizing 
agents. Before thawing, samples were visually inspected 
for separation of plasma and red blood cells which was 
considered to be a sign of prolonged storage at RT prior 
to freezing. All samples were gently thawed on ice and 
2.5 ml was transferred to a PAXgene blood RNA tube and 
incubated for 16 h as previously described [14]. Samples 
extracted with both kits did not show significantly dif-
ferent RNA concentration (Wilcoxon signed rank test 
P = 0.16) whereas the miRNA in small RNA ratio (Agi-
lent 2100 Bioanalyzer) was increased if the PAXgene 
blood miRNA kit was used (Fig. 2a, b).
We next assessed the effect of (1) storage time and 
(2) sample handling before freezing on the RNA qual-
ity and quantity using the PAXgene blood miRNA kit 
and EDTA blood samples derived from 25 horses (Addi-
tional file  3). Samples of two different sampling periods 
were compared (11 short-term stored samples: 12 weeks 
vs. 14 long-term stored samples: 5–11  years): Whereas 
no significant changes in RNA yield could be identified 
between samples of the two sampling periods (Wilcoxon 
rank sum test P = 0.18), the RNA quality was significantly 
lower in long-term stored samples (Wilcoxon rank sum 
test P = 6.10e−4). Phase separation in long-term stored 
samples did not have a significant effect on RNA con-
centration (Wilcoxon rank sum test P  =  0.31), but had 
a significant effect on RNA quality (Wilcoxon rank sum 
test P = 1.02e−4) (Fig. 2c, d). In archived samples with-
out visible phase separation (n = 5), the best RNA quality 
achieved was RQN =  8.3 (sample stored 9  years, Addi-
tional file 3).
All 120 serum and 21 EDTA small RNA samples 
extracted with optimized procedures were success-
fully converted into single-end libraries and sequenced 
on an Illumina HiSeq (Additional file 2). The number of 
sequencing tags after data pre-processing ranged from 
7.1 to 16.5 million.
In this study we showed that compared to human an 
increased volume of equine serum is needed to obtain 
sufficient amounts of small RNA for sequencing, as 
in bovine samples [9]. However, using manual extrac-
tion only 2 ml of serum is needed, compared to 9 ml for 
the previously described extraction with the QIAcube 
robotic system [9]. Similar to [14], we were able to rescue 
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Fig. 1 Sequencing tag length distribution. The reads length distribution of six serum small RNA libraries is shown. The bars indicate mean number 
of tags per sample and the error bars indicate standard errors
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Fig. 2 RNA quality of equine EDTA blood samples. Amount of miRNA (Bioanalyzer, small RNA chip) derived from the same short-term stored sample 
extracted with PAXgene blood RNA (a) or miRNA (b) kit. RNA quality (Fragment Analyzer) of long-term stored samples (11 years) with (c) or without 
(d) phase separation extracted with PAXgene blood RNA kit
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RNA of good quality from some long-term stored equine 
EDTA blood samples via gentle thawing on ice and trans-
fer to a PAXgene blood RNA tube.
Abbreviations
EDTA: ethylenediamine tetraacetic acid; miRNA: micro RNA; RT: room tempera-
ture, i.e. around 20 °C.
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